Regentis Biomaterials (RGNT) Enterprise Value (2024 - 2025)

Regentis Biomaterials (RGNT) reported Enterprise Value of -$7.4 million for Q4 2025, down 3121.83% year-over-year from $244156.4 in Q4 2024, and down 3121.83% quarter-over-quarter from -$229000.0 in Q4 2024.

Regentis Biomaterials (RGNT) Enterprise Value (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 2 years of Enterprise Value data on file, last reported at -$7.4 million in Q4 2025.

  • Enterprise Value for Q4 2025 came in at -$7.4 million, down 3121.83% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.4 million (down 3121.83% YoY), and the FY2025 annual result was -$7.4 million, down 3121.83% from the prior year.
  • Enterprise Value retreated to -$7.4 million in Q4 2025 per RGNT's latest filing, from -$229000.0 in the prior quarter.
  • Over five years, Enterprise Value peaked at -$229000.0 in Q4 2024 and troughed at -$7.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -4.39 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -1.02 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 5.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -1.66 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -521.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -561.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -138.60 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -1.06 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -2.05 Bn
10 Regentis Biomaterials 3.72 Mn -3.66 Mn - -7.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.38 Mn
Dec 31, 2024 -229,000.00